PK and PD Modeling Supports Development of MN-221, a Novel Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Exacerbations of COPD Kazuko Matsuda1, Kirk Johnson1, Alan W. Dunton1, Ernest Kitt1, Brian Sadle

First Page		Document Content
Date: 2014-01-18 12:32:16		PK and PD Modeling Supports Development of MN-221, a Novel Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Exacerbations of COPD Kazuko Matsuda1, Kirk Johnson1, Alan W. Dunton1, Ernest Kitt1, Brian Sadle Add to Reading List Source URL: www.rosaandco.com Download Document from Source Website File Size: 757,00 KB Share Document on Facebook